https://www.selleckchem.com/pr....oducts/BafilomycinA1
There is no correlation with age or sex or severity of the disease; however, they are correlated with ocular symptoms. There is no universal consensus on second-line agents for the treatment of moderate/severe to sight-threatening thyroid eye disease (TED) to maintain remission after first-line intravenous methylprednisolone (IVMP). This study investigates the efficacy and safety of mycophenolate mofetil (MMF) in TED patients in a real-world setting and over a longer period than previous randomized controlled trials. A retrospecti
Like
Comment
Share
